Protocol for Blood Testing

We encourage all of our customers to do blood testing to prove the efficacy of Lonvi PCC1. That is why we have created a standardized blood testing protocol. Please read the below instructions for a quick summary of blood draw schedule, biomarker panels, and testing methods. 

For full descriptions and explanations, please see our Senolytics Efficacy Biomarker Protocol.

Schedule For Blood Testing Regimen:

We recommend following, the below blood draw schedule:

Biomarker Panels (Entry, Intermediate, and Advanced):

We recommend testing the following biomarkers for Entry Level Blood Panel:

We recommend testing the following biomarkers for Intermediate Level Blood Panel: 

For advanced level blood panel, please see the full Senolytics Efficacy Biomarker Protocol.

 

Testing Methods:

If it is practical for you, we recommend utilizing Magnetic Microparticle Chemiluminescence Immunoassay (CLIA) for more accurate results. While Enzyme-Linked Immunosorbent Assay (ELISA) may be the most commonly available testing method for inflammatory biomarkers, it may not be as accurate.

Please see the Senolytics Efficacy Biomarker Protocol for full description of Magnetic Microparticle Chemiluminescence Immunoassay (CLIA).

We have also open sourced our testing protocol for our pre-clinical human study, and included costs for commonly available tests here.